Tests glucose sensors for people with diabetes after leaving hospital
Tests glucose sensor devices in adults with diabetes after hospital discharge.
Key facts
- Who runs it
- Vanderbilt University Medical Center
- Where
- Nashville, United StatesSee the site
- Trial code
- Registry title
- Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge
- Status
- Recruiting
- People taking part
- 60 people, planned
- Started
- 9 Mar 2025
- Expected to end
- Jan 2027
- Type of study
- Interventional, 2 groups
- Treatments tested
- Libre 3 Plus Continuous Glucose Monitor
- Dexcom G7 Continuous Glucose Monitor
- Record updated
- 5 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults in hospital who need insulin for high blood sugar and will keep using it after discharge. It tests wearing a continuous glucose monitor after leaving hospital.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- High blood sugar that needs insulin (injections or the person's own insulin pump) in hospital and at discharge. Recent glucose readings must be 70-350 mg/dL (3.9–19.4 mmol/L).
- Earlier treatment
- Must not have used a Libre 3 Plus or Dexcom G7 monitor in the past 3 months or during this hospital stay.
Main reasons for not taking part
- Pregnant
- Dialysis (hemodialysis or peritoneal)
- Intensive care, intubation, sedation or vasopressors
- Diabetic ketoacidosis or hyperosmotic nonketotic state
- No smartphone that works with the Libre 3 or Dexcom G7 app
The registry criteria, word for word
Show all 18 criteriaShow less
Who can take part
- Non-pregnant adults, ages greater than or equal to 18 years, admitted to VUMC
- Able to give informed consent
- Hyperglycemia requiring insulin therapy including subcutaneous insulin injection or continuous subcutaneous insulin infusion (patient's own insulin pump) during hospitalization and at the time of discharge
- POC glucose or venous glucose levels in the 24 hours prior to participation need to be 70-350 mg/dL
- Need glucose readings greater than or equal to one time per day
- Mental status and dexterity adequate to use Libre 3 Plus or Dexcom G7 sensors with Libre 3 or Dexcom G7 application on patient's smartphone
Who cannot take part
- Currently using Libre 3 Plus or Dexcom G7 CGMS during hospitalization or have used Libre 3 Plus or Dexcom G7 CGMS in the past 3 months
- Received chemotherapy during current hospitalization
- Planning on major surgery within 10-15 days
- Significant pitting edema (3+ or greater) i.e. cirrhosis with ascites, congestive heart failure with edema, nephrotic syndrome, or signs of poor perfusion
- Skin allergy to adhesives
- Does not have smartphone compatible with Libre 3 App or Dexcom G7 App
- Hemodialysis or peritoneal dialysis
- Requiring vasopressors, intubation, sedation, or admission to an intensive care unit
- Vitamin C use of more than 500 milligrams per day
- Hydroxyurea use
- Acetaminophen use of more than 4 grams per day or 1 gram every 6 hours
- Presentation in diabetic ketoacidosis or hyperosmotic nonketotic state
Where in United States
- Vanderbilt University Medical CenterNashville, United StatesContact: Angel Morvant, MDTaking people
About the trial
What the trial wants to find out
This study aims to improve patient awareness of the utility of continuous glucose monitoring systems in blood glucose monitoring and to improve patient satisfaction regarding diabetes care, particularly in the matter of blood glucose monitoring, at the transitions of care from the inpatient setting to the ambulatory setting.
The 2 groups in the trial
- Libre 3 Plus Continuous Glucose MonitorTreatment being tested
Subjects in this arm will start using the Libre 3 Plus continuous glucose monitor.
- Dexcom G7 Continuous Glucose MonitorTreatment being tested
Subjects in this arm will start using the Dexcom G7 continuous glucose monitor.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge
- Plain-language title
- Tests glucose sensors for people with diabetes after leaving hospitalGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 5 March 2026